Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-07

Clinical Trial Update: Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating two trabecular micro-bypass stents plus postoperative travoprost in open-angle glaucoma patients already using two antihypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trabecular micro-bypass stent (two stents)
  • Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Glaukos Corporation | Conditions: Open-angle Glaucoma | Phase 4 | Status: COMPLETED